Navigation Links
Most Prostate Cancer Patients Don't Die From the Disease: Study
Date:7/30/2012

By Steven Reinberg
HealthDay Reporter

FRIDAY, July 27 (HealthDay News) -- Men with prostate cancer are more likely to die from other conditions, such as heart disease, than from their cancer, a new study finds.

Living a healthy lifestyle that helps prevent chronic diseases can prolong life even among men with prostate cancer, the researchers added.

"Our study is the first to analyze specific causes of death among men with prostate cancer," said lead researcher Mara Epstein, a postdoctoral researcher at the Harvard School of Public Health in Boston.

Most men who died from prostate cancer over several decades of the study were men diagnosed when they were older or diagnosed before the advent of screening for prostate-specific antigen (PSA), she noted.

"We hope the study will have an impact on the clinical management of men who receive a diagnosis of prostate cancer," Epstein said.

"We hope it will encourage physicians to use the diagnosis as a teachable moment to encourage men to modify lifestyle factors, like losing weight, increasing physical activity and stopping smoking," she explained. "We believe that adopting a healthier lifestyle may reduce a man's risk of other chronic medical conditions that ultimately account for more deaths among men with prostate cancer than the disease itself."

The report was published July 25 in the online edition of the Journal of the National Cancer Institute.

For the study, Epstein's team used the U.S. Surveillance, Epidemiology, and End Results Program and the Swedish Cancer and Cause of Death registries to collected data on the causes of death among more than 700,000 men.

U.S. deaths were for 1973 through 2008; for Swedish men it was 1961 through 2008, the team noted.

Over these periods, 52 percent of the Swedish men with prostate cancer died, as did 30 percent of American men with prostate cancer in the study.

Of these deaths, h
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. New drug prevents spread of human prostate cancer cells
2. 2 genetic deletions in human genome linked to the development of aggressive prostate cancer
3. Intensity Modulated Radiation Therapy optimal for localized prostate cancer
4. Study examines adverse effects among different radiation therapies for prostate cancer
5. Study Casts Doubt on Value of Pricey Prostate Cancer Therapy
6. Warren Buffett Has Early Stage Prostate Cancer
7. Genetic abnormalities in benign or malignant tissues predict relapse of prostate cancer
8. PSA screening to detect prostate cancer can be beneficial to younger and at-risk men
9. Mayo Clinic researchers discover biomarkers for prostate cancer detection, recurrence
10. Quality of care, other issues may cause worse results in black prostate cancer surgery patients
11. Higher hospital volume more important than surgeon experience in outcome of prostate cancer surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... 20, 2013 Sporturf, an international manufacturer ... its presence in the Midwest with the opening of ... Missouri. Sporturf Midwest is under the leadership of ... Missouri and Kansas. , “This strategic move ... been in before,” noted Shonk. “Bringing an ISO manufacturer ...
(Date:5/20/2013)... Online education provides the convenience, ... does not offer. According to the American Heart ... switching classroom learning to eLearning due to changing ... helped maximize training budgets, but it is also ... by 25–60%. A higher retention of content is ...
(Date:5/20/2013)... limb is lost as a consequence of diabetic foot ... that can change this situation are very limited. In ... School and the Department of Medical Biochemistry and Biophysics ... wound treatment that may completely change the lives of ... severe type of chronic wounds that largely impair the ...
(Date:5/20/2013)... 2013 BenefitMall, the leading ... payroll products and services and CompuPay, Inc., ... as finalists for the 2013 American Business Awards. BenefitMall ... Year category, and CompuPay is a finalist for Customer ... be a Gold, Silver or Bronze Stevie® Award Winner ...
(Date:5/20/2013)... 2013 Soliant Health, a leading specialty healthcare ... voting for its fifth annual Most Beautiful Hospitals in the ... year, Soliant decided to bypass its routine selection process and ... received to be in the running for the 2013 Most ... May 20 and runs through June 23. Winners will be ...
Breaking Medicine News(10 mins):Health News:Sporturf Expands into the Midwestern U.S. 2Health News:Swank HealthCare Announces New Offering of Additional American Heart Association’s Accredited Online Courses 2Health News:Discovery of a novel medicine for the treatment of chronic wounds 2Health News:BenefitMall And CompuPay, Inc., A BenefitMall Company, Named As Finalists In 2013 American Business Awards 2Health News:BenefitMall And CompuPay, Inc., A BenefitMall Company, Named As Finalists In 2013 American Business Awards 3Health News:Vote for Soliant Health's 2013 Most Beautiful Hospitals in the U.S. 2Health News:Vote for Soliant Health's 2013 Most Beautiful Hospitals in the U.S. 3Health News:Vote for Soliant Health's 2013 Most Beautiful Hospitals in the U.S. 4Health News:Vote for Soliant Health's 2013 Most Beautiful Hospitals in the U.S. 5Health News:Vote for Soliant Health's 2013 Most Beautiful Hospitals in the U.S. 6Health News:Vote for Soliant Health's 2013 Most Beautiful Hospitals in the U.S. 7Health News:Vote for Soliant Health's 2013 Most Beautiful Hospitals in the U.S. 8Health News:Vote for Soliant Health's 2013 Most Beautiful Hospitals in the U.S. 9
... In a research study appearing in the journal ... Harbor Laboratory (CSHL) and four other institutions have identified a ... has limited treatment options and one of the worst one-year ... that up to 15% of liver tumors are "driven" by ...
... Mutations in three pathways important for suppressing tumors ... that strikes children and adults. But new research ... those changes alone are not sufficient to cause ... different points in the same disrupted regulatory pathways. ...
... Spanish . The Hospital Clnic of Barcelona presented today ... Felipe Garcia and Dr. Agata Len , from the Hospital ... Gatell . The tool has been created by a team from the ... and Csar Cceres . Through a direct connection via a webcam, ...
... Researchers at Georgia Health Sciences University are studying whether ... metabolite could halt the progression of diabetic nephropathy, or ... year, $308,000 grant from the American Heart Association, Dr. ... College of Dental Medicine and Pharmacology and Toxicology in ...
... the brain transmits messages to other parts of the ... dementia, multiple sclerosis and stroke. Scientists at the ... maintaining the health and function of the segment of ... brain. The study, published in the journal ...
... U.S. Department of Energy,s (DOE) Brookhaven National Laboratory, Stony ... a "wearable," portable PET scanner they,ve developed for rats. ... simultaneously studying brain function and behavior in fully awake, ... validation studies in the April 2011 issue of Nature ...
Cached Medicine News:Health News:Study identifies therapeutic target for liver cancer and predictive biomarker of response 2Health News:Study identifies therapeutic target for liver cancer and predictive biomarker of response 3Health News:Key mutations act cooperatively to fuel aggressive brain tumor 2Health News:Key mutations act cooperatively to fuel aggressive brain tumor 3Health News:Virtual assistance is confirmed as an effective tool in monitoring HIV patients 2Health News:Virtual assistance is confirmed as an effective tool in monitoring HIV patients 3Health News:Miniature 'wearable' PET scanner ready for use 2Health News:Miniature 'wearable' PET scanner ready for use 3Health News:Miniature 'wearable' PET scanner ready for use 4
(Date:5/20/2013)... Md. , May 20, 2013  Neuralstem, Inc. ... Feldman , MD, PhD, principal investigator, presented updated ... stem cell (NSI-566) trial in the treatment of amyotrophic ... ,s disease) at the neuro diabetes special medical symposium ... In a talk called "Recent Therapeutic Advances in Stem ...
(Date:5/19/2013)... 20, 2013 Claret Medical, Inc. announced the publication ... Mieghem et al., Histopathology of Embolic Debris ... print in Circulation, May 7 th this research is ... Rotterdam, the Netherlands and the pathology team ... Cardiovascular Pathology Institute, Gaithersburg, Maryland.  This is ...
(Date:5/18/2013)... , May 18, 2013 Faruqi & ... is investigating potential securities fraud at AVEO Pharmaceuticals, ... (Logo: http://photos.prnewswire.com/prnh/20120119/MM38856LOGO ) ... its executives violated federal securities laws by issuing ... Phase III drug trials for Tivopath (tivozanib) (titled ...
Breaking Medicine Technology:Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 2Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 3Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania 4Claret Medical, Inc. Announces Publication of the First Clinical Research on the Frequency and Composition of Embolic Debris Captured during TAVR 2Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm 2
... N.J., May 14, 2012  MAQUET Cardiovascular LLC, a leading ... received 510(k) clearance from the U.S. Food and Drug ... 40cc intra-aortic balloon (IAB) catheters. These new, larger volume ... hemodynamic support, regardless of their height.  ...
... The increasing incidence of thrombosis, paralleled by ... motivating the need for novel alternatives. Establishing end-user ... market advancement. However, the launch of three blockbuster ... therapeutics market address these challenges. It is also ...
Cached Medicine Technology:MAQUET Cardiovascular Receives FDA 510(k) Clearance For New Mega® Intra-Aortic Balloon Catheter Sizes 2MAQUET Cardiovascular Receives FDA 510(k) Clearance For New Mega® Intra-Aortic Balloon Catheter Sizes 3European Thrombosis Therapeutics Market is Experiencing an Urgent Need for Enhanced Products, Says Frost & Sullivan 2European Thrombosis Therapeutics Market is Experiencing an Urgent Need for Enhanced Products, Says Frost & Sullivan 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: